TCOM, PII among premarket gainers
Eastman Kodak (NYSE:KODK) 190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) 52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) 44% on en
TCOM, PII among premarket gainers
Eastman Kodak (NYSE:KODK) 190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) 52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) 44% on en